The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Human Rotavirus Vaccine-Global Market Insights and Sales Trends 2024
Synopsis
Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease.
The global Human Rotavirus Vaccine market size is expected to reach US$ 10360 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Human Rotavirus Vaccine in various end use industries. The expanding demands from the Hospitals & Clinics, Academic And Research and Others,, are propelling Human Rotavirus Vaccine market. Rotarix, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RotaTeq segment is estimated at % CAGR for the next seven-year period.
Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. The vaccine first became available in the United States in 2006.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Rotavirus Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Rotavirus Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Rotavirus Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Rotavirus Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Rotavirus Vaccine covered in this report include Bharat Biotech, Merck and GlaxoSmithKline, etc.
The global Human Rotavirus Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bharat Biotech
Merck
GlaxoSmithKline
Global Human Rotavirus Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Rotavirus Vaccine market, Segment by Type:
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Global Human Rotavirus Vaccine market, by Application
Hospitals & Clinics
Academic And Research
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Rotavirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease.
The global Human Rotavirus Vaccine market size is expected to reach US$ 10360 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Human Rotavirus Vaccine in various end use industries. The expanding demands from the Hospitals & Clinics, Academic And Research and Others,, are propelling Human Rotavirus Vaccine market. Rotarix, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RotaTeq segment is estimated at % CAGR for the next seven-year period.
Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. The vaccine first became available in the United States in 2006.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Rotavirus Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Rotavirus Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Rotavirus Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Rotavirus Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Rotavirus Vaccine covered in this report include Bharat Biotech, Merck and GlaxoSmithKline, etc.
The global Human Rotavirus Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bharat Biotech
Merck
GlaxoSmithKline
Global Human Rotavirus Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Rotavirus Vaccine market, Segment by Type:
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Global Human Rotavirus Vaccine market, by Application
Hospitals & Clinics
Academic And Research
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Rotavirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Human Rotavirus Vaccine Market Overview
1.1 Human Rotavirus Vaccine Product Overview
1.2 Human Rotavirus Vaccine Market Segment by Type
1.2.1 Rotarix
1.2.2 RotaTeq
1.2.3 Rotavac
1.2.4 Rotavin-M1
1.2.5 Lanzhou lamb
1.2.6 Others
1.3 Global Human Rotavirus Vaccine Market Size by Type
1.3.1 Global Human Rotavirus Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Human Rotavirus Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Human Rotavirus Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Rotavirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Human Rotavirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Human Rotavirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Human Rotavirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Human Rotavirus Vaccine Sales Breakdown by Type (2018-2023)
2 Global Human Rotavirus Vaccine Market Competition by Company
2.1 Global Top Players by Human Rotavirus Vaccine Sales (2018-2023)
2.2 Global Top Players by Human Rotavirus Vaccine Revenue (2018-2023)
2.3 Global Top Players by Human Rotavirus Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Human Rotavirus Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Rotavirus Vaccine Market Competitive Situation and Trends
2.5.1 Human Rotavirus Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Rotavirus Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Rotavirus Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Human Rotavirus Vaccine Market
2.8 Key Manufacturers Human Rotavirus Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Rotavirus Vaccine Status and Outlook by Region
3.1 Global Human Rotavirus Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Human Rotavirus Vaccine Historic Market Size by Region
3.2.1 Global Human Rotavirus Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Human Rotavirus Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Human Rotavirus Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Human Rotavirus Vaccine Forecasted Market Size by Region
3.3.1 Global Human Rotavirus Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Human Rotavirus Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Human Rotavirus Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Human Rotavirus Vaccine by Application
4.1 Human Rotavirus Vaccine Market Segment by Application
4.1.1 Hospitals & Clinics
4.1.2 Academic And Research
4.1.3 Others
4.2 Global Human Rotavirus Vaccine Market Size by Application
4.2.1 Global Human Rotavirus Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Human Rotavirus Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Human Rotavirus Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Rotavirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Human Rotavirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Human Rotavirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Human Rotavirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Human Rotavirus Vaccine Sales Breakdown by Application (2018-2023)
5 North America Human Rotavirus Vaccine by Country
5.1 North America Human Rotavirus Vaccine Historic Market Size by Country
5.1.1 North America Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Human Rotavirus Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Human Rotavirus Vaccine Sales in Value by Country (2018-2023)
5.2 North America Human Rotavirus Vaccine Forecasted Market Size by Country
5.2.1 North America Human Rotavirus Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Human Rotavirus Vaccine Sales in Value by Country (2024-2029)
6 Europe Human Rotavirus Vaccine by Country
6.1 Europe Human Rotavirus Vaccine Historic Market Size by Country
6.1.1 Europe Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Human Rotavirus Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Human Rotavirus Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Human Rotavirus Vaccine Forecasted Market Size by Country
6.2.1 Europe Human Rotavirus Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Human Rotavirus Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Rotavirus Vaccine by Region
7.1 Asia-Pacific Human Rotavirus Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Human Rotavirus Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Human Rotavirus Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Human Rotavirus Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Rotavirus Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Human Rotavirus Vaccine Sales in Value by Region (2024-2029)
8 Latin America Human Rotavirus Vaccine by Country
8.1 Latin America Human Rotavirus Vaccine Historic Market Size by Country
8.1.1 Latin America Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Human Rotavirus Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Human Rotavirus Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Human Rotavirus Vaccine Forecasted Market Size by Country
8.2.1 Latin America Human Rotavirus Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Human Rotavirus Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Rotavirus Vaccine by Country
9.1 Middle East and Africa Human Rotavirus Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Human Rotavirus Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Human Rotavirus Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Human Rotavirus Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Rotavirus Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Human Rotavirus Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bharat Biotech
10.1.1 Bharat Biotech Company Information
10.1.2 Bharat Biotech Introduction and Business Overview
10.1.3 Bharat Biotech Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bharat Biotech Human Rotavirus Vaccine Products Offered
10.1.5 Bharat Biotech Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Human Rotavirus Vaccine Products Offered
10.2.5 Merck Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GlaxoSmithKline Human Rotavirus Vaccine Products Offered
10.3.5 GlaxoSmithKline Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Rotavirus Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Rotavirus Vaccine Industrial Chain Analysis
11.4 Human Rotavirus Vaccine Market Dynamics
11.4.1 Human Rotavirus Vaccine Industry Trends
11.4.2 Human Rotavirus Vaccine Market Drivers
11.4.3 Human Rotavirus Vaccine Market Challenges
11.4.4 Human Rotavirus Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Rotavirus Vaccine Distributors
12.3 Human Rotavirus Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
